Valuation Grifols, S.A.

Equities

Market Closed - BME Other stock markets 09:05:55 06/09/2024 pm IST			5-day change	1st Jan Change
9.306 ^EUR	-2.21%		-7.13%	-39.79%

06/09	European Equities Traded in the US as American Depositary Receipts Decline in Friday Trading; Index Set to End Week 3.7% Lower	MT
05/09	European Equities Traded in the US as American Depositary Receipts Lower in Thursday Trading	MT

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Capitalization ¹	18,760	14,161	9,783	6,557	9,231	5,921	-	-
Change	-	-24.52%	-30.92%	-32.97%	40.77%	-35.85%	-	-
Enterprise Value (EV) ¹	25,225	20,597	16,478	15,716	18,568	15,082	14,565	14,204
Change	-	-18.35%	-20%	-4.63%	18.15%	-18.78%	-3.42%	-2.48%
P/E ratio	34.5x	26.5x	62.5x	34.7x	172x	14.9x	9.89x	8.12x
PBR	4.46x	1.99x	1.89x	1.19x	1.79x	1.1x	0.95x	0.86x
PEG	-	-24.12x	-0.9x	2.3x	-2.4x	0x	0.2x	0.4x
Capitalization / Revenue	3.68x	2.65x	1.98x	1.08x	1.4x	0.84x	0.78x	0.73x
EV / Revenue	4.95x	3.86x	3.34x	2.59x	2.82x	2.13x	1.91x	1.75x
EV / EBITDA	17.9x	13.9x	17.1x	12.9x	12.8x	8.4x	7.07x	6.32x
EV / EBIT	22.3x	20.7x	27.7x	19.5x	18.1x	11.9x	9.54x	8.52x
EV / FCF	161x	25.7x	52.1x	-56.7x	-213x	54.7x	23x	15.8x
FCF Yield	0.62%	3.9%	1.92%	-1.76%	-0.47%	1.83%	4.35%	6.34%
Dividend per Share ²	0.36	0.17	0.36	-	-	0.0001	0.1276	0.3146
Rate of return	1.15%	0.71%	2.13%	-	-	0%	1.37%	3.38%
EPS ²	0.91	0.9	0.27	0.31	0.09	0.6232	0.9411	1.146
Distribution rate	39.6%	18.9%	133%	-	-	0.02%	13.6%	27.4%
Net sales ¹	5,099	5,340	4,933	6,064	6,592	7,081	7,616	8,135
EBITDA ¹	1,407	1,479	961.5	1,221	1,455	1,795	2,061	2,246
EBIT ¹	1,131	996.1	595.1	805.7	1,023	1,266	1,527	1,667
Net income ¹	625.1	618.5	182.8	208.3	59.32	397.7	614.9	747.6
Net Debt ¹	6,465	6,436	6,695	9,158	9,337	9,160	8,644	8,283
Reference price ²	31.430	23.880	16.875	10.770	15.455	9.306	9.306	9.306
Nbr of stocks (in thousands)	6,84,135	6,84,540	6,82,484	6,78,911	6,78,665	6,79,629	-	-
Announcement Date	27/02/20	26/02/21	28/02/22	28/02/23	28/02/24	-	-	-

¹EUR in Million²EUR

Estimates

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E ratio	EV / Sales	EV / EBITDA	Yield (Y)	Capi. ($)
GRIFOLS, S.A.	14.93x	2.13x	8.4x	+0.00%	6.58B
CSL LIMITED	31.46x	6.83x	19.94x	+1.47%	98.35B
SAMSUNG BIOLOGICS CO.,LTD.	65.34x	15.4x	35.9x	-.--%	51.57B
UCB	71.29x	5.56x	23.29x	+0.88%	33.79B
BIOGEN INC.	15.72x	3.37x	9.7x	-.--%	29.25B
BIOMARIN PHARMACEUTICAL INC.	40.68x	5.48x	27.67x	-.--%	16.01B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	162.77x	29.4x	90.88x	+0.10%	12.25B
ALTEOGEN INC.	2229.63x	212.04x	-3467.97x	-	12.01B
INCYTE CORPORATION	66.62x	2.21x	27.25x	-.--%	11.8B
SWEDISH ORPHAN BIOVITRUM AB	32.02x	4.82x	13.39x	-.--%	10.27B
Average	273.05x	28.72x	-321.16x	+0.27%	28.19B
Weighted average by Cap.	141.77x	17.15x	-123.05x	+0.65%